+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Odefsey"

Global HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Global HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
HIV Disease Coverage Forecast and Market Analysis to 2027 - Product Thumbnail Image

HIV Disease Coverage Forecast and Market Analysis to 2027

  • Drug Pipelines
  • June 2019
  • 579 Pages
  • Global
Disease Analysis: HIV Treatment - Product Thumbnail Image

Disease Analysis: HIV Treatment

  • Report
  • April 2021
  • 64 Pages
  • Global
HIV Disease Coverage Forecast and Market Analysis to 2024 - Product Thumbnail Image

HIV Disease Coverage Forecast and Market Analysis to 2024

  • Report
  • January 2019
  • 717 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

The Odefsey market is a subset of the HIV/AIDS drug market, focusing on the development and distribution of antiretroviral drugs. These drugs are used to treat HIV infection and reduce the risk of HIV transmission. Odefsey is a combination of two drugs, emtricitabine and rilpivirine, which are used in combination with other antiretroviral drugs to treat HIV infection. Odefsey is a once-daily, single-tablet regimen that is designed to be taken with or without food. It is approved for use in adults and adolescents aged 12 years and older. The Odefsey market is highly competitive, with several major pharmaceutical companies competing for market share. These companies include Gilead Sciences, Janssen Pharmaceuticals, Merck & Co., and ViiV Healthcare. Each of these companies has developed and marketed their own version of Odefsey, and they are continually striving to improve the efficacy and safety of their products. Show Less Read more